Role of Selective Serotonin Reuptake Inhibitors in the Treatment of Hypochondriasis: A Systematic Review

selective serotonin reuptake inhibitors and cardiovascular events: a systematic review

background: given the importance of the role of depression in predicting the outcome of cardiovascular disorders, current medications for treating depression, particularly selective serotonin reuptake inhibitors (ssris), are taken into  consideration. this study aimed to systematically review the published findings in the use of ssris and the risk for cardiac events. materials and methods: an i...

Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review.

OBJECTIVES An understanding of cerebro-vascular effects of selective serotonin reuptake inhibitors (SSRIs) is essential, since SSRIs are a widely used antidepressant, serotonin is a vasoactive and thrombostatic amine, and there is a bidirectional relationship between depression and cerebrovascular disease. DATA SOURCES A MEDLINE search was performed to identify published reports over the peri...

Selective Serotonin Reuptake Inhibitors: A Class Review

OVERVIEW Many changes and therapeutic advances have occurred in the treatment of depression in recent years, most notably the availability of the selective serotonin reuptake inhibitor (SSRI) class of agents, followed by the introduction of escitalopram oxalate (LexaproTM, Forest), the first agent in what is known as the “second generation” of SSRIs. However, because of the higher acquisition c...

Selective Serotonin Reuptake Inhibitors

It has long been postulated that a deficiency in CNS serotonergic activity is the cause of, or a predisposing factor for, depression. [1] However, the evidence for this association is largely circumstantial and it certainly does not represent an adequate and full model for depression, probably due to there being multiple aetiological factors. [2] Some pharmacological trial data also cast doubt ...

Selective serotonin reuptake inhibitors.